Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma

Cancer

Volumn 83, Issue 11, 1998, Pages 2346-2352

  Santin, Alessandro D ^a,b,c   Hermonat, Paul L ^a   Ravaggi, Antonella ^a,b   Chiriva Internati, Maurizio ^a,b   Pecorelli, Sergio ^b   Parham, Groesbeck P ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

Author keywords

Cervical carcinoma; E6; E7; Human papillomavirus; Irradiation; Major histocompatibility complex

Indexed keywords

ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; GAMMA IRRADIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; WART VIRUS;

CELL TRANSFORMATION, VIRAL; FEMALE; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, VIRAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; ONCOGENES; PAPILLOMAVIRIDAE; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0032400872     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981201)83:11<2346::AID-CNCR14>3.0.CO;2-G     Document Type: Article

References (40)

1. Bosh FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87: 796-802.
2. Brinton LA. Epidemiology of cervical cancer: overview. In: Munoz N, Bosh FX, Shah KV, Meheus A, editors. The epidemiology of human papillomavirus and cervical cancer. Lyon, France: IARC Science Publications, 1992;119:3-23.
3. Zur Hausen H. Intracellular surveillance of persisting viral infections: human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet 1986;2:489-91.
4. Penn I. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer 1988;53:539-45.
5. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Brocker TR. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 1992;23:117-28.
6. Higgins GD, Uzelin DM, Phillips GE, McEvoy P, Marin R, Burrel CJ. Transcription pattern of human papillomavirus type 16 in genital intraepithelial neoplasia: evidence for promoter usage within the E7 open reading frame during epithelial differentiation. J Gen Virol 1992;73:2047-57.
7. Connor ME, Stern PL. Loss of MHC Class-I expression in cervical carcinomas. Int J Cancer 1990;46:1029-34.
8. Honma S, Tsukada S, Honda S, Nakamura M, Takakuwa K, Maruhashi T, et al. Biological-clinical significance of selective loss of HLA-class I allelic product expression in squamous-cell carcinoma of the uterine cervix. Int J Cancer 1994; 57:650-5.
9. Hall EJ. Time, dose, and fractionation in radiotherapy. In: Hall D, editor. Radiobiology for the radiologist. 3rd edition. Philadelphia: J.B. Lippincott Company, 1988:239-59.
10. Hareyama M, Imai K, Kubo K, Takahashi H, Koshiba H, Hinoda Y, et al. Effect of radiation on the expression of carcinoembryonic antigen of human gastric adenocarcinoma cells. Cancer 1991;67:2269-74.
11. b in B16 melanoma cells. Cancer Res 1993;53:1952-5.
12. Hill BT, Whelan RDH, Hurst HC, McClean S. Identification of a distinctive P-glycoprotein-mediated resistance phenotype in human ovarian carcinoma cells after their in vitro exposure to fractionated X-irradiation. Cancer 1994;73: 2990-9.
13. Yee C, Krishhnan-Hewlett I, Backer CC, Schlegel R, Howley PM. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985;119:361-6.
14. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
15. Carreno BM, Winter CC, Taurog JD, Hansen TH, Biddison WE. Residues in pockets B and F of HLA-B27 are critical in the presentation of an influenza A virus nucleoprotein peptide and influence destability of peptide-MCH complex. Intern Immunol 1993;5:353-60.
16. Feinberg AP, Volgestein D. A technique for radiolabeling DNA restriction fragments to high specific activity. Anal Biochem 1983;13:212-6.
17. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 1987;61:962-71.
18. Scheffner M, Werness BA, Huibregtse JM, Howley PM. The E6 oncoprotein encoded by human papilloma virus 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36.
19. Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934-7.
20. Von Knebel Doebeberitz M, Gissman L, Zur Hausen H. Growth-regulating functions of human papillomavirus early proteins in cervical cancer cells acting dominant overenhanced epidermal growth factor receptor expression. Cancer Res 1990;50:3730-6.
21. Von Knebel Doebeberitz M, Oltersdorf T, Schwarz E, Gissman L. Correlation of modified human papillomavirus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res 1988;48:3780-6.
22. Steele C, Cowsert LM, Shillitoe EJ. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines. Cancer Res 1993;53:2330-7.
23. Hamada K, Sakaue M, Alemany R, Zhang W-W, Horio Y, Roth JA, et al. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells. Gynecol Oncol 1996;63:219-27.
24. Evans E M-L, Man S, Evans AS, Borysiewics LK. Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. Cancer Res 1997;57:2943-50.
25. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long term follow-up. Obstet Gynecol 1986; 67:665-9.
26. Maiman M, Fruchter RG, Serur E, Remy JC, Feuer G, Boyce J. Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol 1990;38:377-82.
27. Riout G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Orth G. Association between poor prognosis in early-stage invasive cervical carcinoma and non-detection of HPV DNA. Lancet 1990;335:1171-4.
28. Higgins GD, Davy M, Roder D, Uzelin DM, Phillips GE, Burrel CJ. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 1991;338:910-3.
29. Taylor JL, Grossberg SE. Recent progress in Interferon research: molecular mechanisms of regulation, action and virus circumvention. Virus Res 1990;15:1-26.
30. Street D, Kaufmann AM, Vaughan A, Fisher SG, Hunter M, Schreckenberger C, et al. Interferon-γ enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells. Gynecol Oncol 1997;65:265-72.
31. Chen L, Thomas EK, Hu S-L, Hellstrom I, Hellstrom KE. Human papilloma virus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci USA 1991;88:110-4.
32. Chen L, Mizuno MT, Singal MC, Hu S-L, Galloway DA, Hellstrom I, et al. Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papilloma virus type 16. J Immunol 1992;148: 2617-21.
33. Chambers MA, Wei Z, Coleman N, Nash AA, Stanley MA. "Natural" presentation of human papillomavirus type-16 E7 protein to immunocompetent mice results in antigen-specific sensitization or sustained unresponsiveness. Eur J Immunol 1994;24:738-45.
34. Alexander M, Salgaller ML, Celis E, Sette A, Barnes WA, Rosenberg SA, et al. Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope. Am J Obstet Gynecol 1996; 175:1586-93.
35. Glew SS, Duggan-Keen M, Cabrera T, Stern PL. HLA class II expression in human papillomavirus-associated cervical cancer. Cancer Res 1992;52:4009-16.
36. Coleman N, Stanley MA. Analysis of HLA-DR expression on keratinocytes in cervical neoplasia. Int J Cancer 1994;56: 314-9.
37. Xu Y, Conway B, Montaner JS, O'Shaughnessy MV, Greenstock CL. Effects of low dose-gamma radiation of HIV replication in human peripheral blood mononuclear cells. Photochem Photobiol 1996;64:238-41.
38. Nokta M, Belli J, Pollard R. X-irradiation enhances in vitro human immunodeficiency virus replication: correlation with cellular levels of Camp. J Proc Soc Exp Biol Med 1992; 200:402-8.
39. Hill BT. Interaction between antitumor agents and radiation and the expression of resistance. Cancer Treat Rev 1991;18: 149-90.
40. McClean S, Hosking LK, Hill BT. Expression of P-glycoprotein-mediated resistance in CHO cells surviving a single X-ray dose of 30 Gy. Int J Radiat Biol Oncol Phys 1993;63: 765-73.